Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
0.7170
+0.0295 (4.29%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Ocugen Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Ocugen stock have an average target of 6.33, with a low estimate of 4.00 and a high estimate of 8.00. The average target predicts an increase of 782.85% from the current stock price of 0.72.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 6, 2025.
Analyst Ratings
The average analyst rating for Ocugen stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $6 → $7 | Strong Buy | Maintains | $6 → $7 | +876.29% | Mar 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +1,015.76% | Mar 6, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $6 | Strong Buy | Maintains | $6 | +736.82% | Feb 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +1,015.76% | Feb 13, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $6 | Strong Buy | Maintains | $6 | +736.82% | Jan 23, 2025 |
Financial Forecast
Revenue This Year
n/a
from 4.05M
Revenue Next Year
374.00K
EPS This Year
-0.25
from -0.20
EPS Next Year
-0.25
from -0.25
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 1.2M | 119.7M | ||
| Avg | n/a | 374,003 | 110.0M | ||
| Low | n/a | n/a | 99.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 31,894.4% | ||
| Avg | - | - | 29,298.1% | ||
| Low | - | - | 26,528.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.22 | -0.23 | 0.03 | ||
| Avg | -0.25 | -0.25 | -0.04 | ||
| Low | -0.31 | -0.26 | -0.11 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.